Speaker illustration

Professor Nikolaus Marx

RWTH University Hospital Aachen, Aachen (Germany)

Member of:

European Society of Cardiology

Nikolaus Marx, born in 1968, is Professor of Medicine / Cardiology and Head of the Department of Internal Medicine I, University Hospital Aachen, Germany. He received his medical training at the Universities of Mainz, Genf (Switzerland) and Düsseldorf, obtaining his MD in 1994. After a post-doctoral fellowship with Dr. Peter Libby and Dr. Jorge Plutzky at Brigham and Women's Hospital, Harvard Medical School, Nikolaus Marx later became a board-certified internist, then cardiologist, before specialising in intensive care medicine in internal medicine at the University of Ulm. He was appointed Professor of Medicine / Cardiology and Head of the Department of Internal Medicine I at the University of Aachen in 2009. Professor Marx has a longstanding research interest (basic science, translational science, clinical trials) in cardiovascular disease in patients with comorbidities including diabetes and chronic kidney disease.

Guidelines in Practice: 2023 ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes

Event: ESC Congress 2023

Topic: Diabetes and the Heart

Session type: New ESC Guidelines

Thumbnail

A multidisciplinary approach to type 2 diabetes, obesity, and cardiovascular diseases: current evidence and a glimpse into the future

Event: ESC Congress 2023

Topic: Obesity and Diabetes

Session type: Satellite Symposium

Thumbnail

2023 ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes

Event: ESC Congress 2023

Topic: Diabetes and the Heart

Session type: New ESC Guidelines

Thumbnail

2023 ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes: Ask the Guidelines Task Force

Event: ESC Congress 2023

Topic: Diabetes and the Heart

Session type: New ESC Guidelines

Thumbnail

Basic and Translational Late-Breaking Science 1

Event: ESC Congress 2022

Topic: Basic Science

Session type: Basic and Translational Late-Breaking Science

Thumbnail

Renal failure and cardiovascular disease 1

Event: ESC Congress 2022

Topic: Renal Failure and Cardiovascular Disease

Session type: Moderated ePosters

Thumbnail

What the cardiologist must know: glucose-lowering medication after myocardial infarction in hospital and after discharge

Event: ESC Congress 2022

Topic: Risk Factors and Prevention

Session type: Official Joint Session

Thumbnail

Modern Glycaemic Management to reduce CV risk in Diabetes

Event: ESC Congress 2021 - The Digital Experience

Topic: Cardiovascular Disease in Special Populations

Session type: Satellite Symposium

Thumbnail

SGLT2 inhibitors and cardiovascular outcomes

Event: ESC Congress 2019

Topic: Pharmacotherapy

Session type: Symposium

Thumbnail

Expanding opportunities for SGLT2i in clinical cardiology

Event: ESC Congress 2019

Topic: Risk Factors and Prevention

Session type: Satellite Symposium

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb